Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAXCIS: Docetaxel-Cisplatin Induction and Concurrent Chemoradiotherapy in NSCLC
NCT03371550Phase 2Completed
- Sponsor
- Centre Antoine Lacassagne
- Start
- Aug 2004
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of docetaxel, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Centre Antoine Lacassagne. Started Aug 2004; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03371550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371550.